Pharma News
Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.
Sanofi to Acquire Blueprint Medicines to Strengthen Rare Immunological Disease Portfolio
Monday, June 02, 2025Sanofi has announced plans to acquire Blueprint MedicinesThis acquisition will enhance Sanofis position in the immunology space bringing both a marketed therapy and a promising pipeline of new treatments
Nxera Pharma Begins Collaboration with Lilly to Develop Treatments for Metabolic Diseases
Monday, June 02, 2025Nxera Pharma has reached a significant development milestone under its ongoing collaboration and licence agreement with Eli Lilly and Company focused on diabetes and other metabolic diseases
Moderna’s mNEXSPIKE COVID-19 Vaccine Approved by U.S. FDA
Saturday, May 31, 2025Moderna has received approval from the US Food and Drug Administration FDA for its latest COVID vaccine mNEXSPIKE mRNAThe vaccine is authorised for use in adults aged and older as well as individuals aged to who have one or more underlying health...
Astellas Secures Global Rights to Investigational CLDN18.2-Targeting ADC XNW27011 from Evopoint
Saturday, May 31, 2025Astellas Pharma has entered into an exclusive global licence agreement with Evopoint Biosciences for XNW a clinicalstage antibodydrug conjugate ADC designed to target CLDN
Mabwell Secures NMPA Approval for MAILISHENG (Albipagrastim alfa for Injection)
Saturday, May 31, 2025Mabwell has received marketing approval from the National Medical Products Administration NMPA in China for its new drug Albipagrastim alfa for Injection MAILISHENG
Beam Therapeutics Granted FDA Orphan Drug Designation for BEAM-302 in Alpha-1 Antitrypsin Deficiency
Friday, May 30, 2025Beam Therapeutics has announced that the United States Food and Drug Administration FDA has granted orphan drug designation to BEAM a treatment candidate for alpha antitrypsin deficiency AATD
SK bioscience Expands Manufacturing Capacity to Enhance Global Vaccine Supply
Friday, May 30, 2025SK bioscience has completed a significant expansion of its vaccine production site L HOUSE in Andong South KoreaThe development is part of the companys efforts to strengthen its global vaccine manufacturing infrastructure and support broader access t...
Sarah Cannon Research Institute Enters into Partnership with AbbVie to Advance Cancer Therapies
Thursday, May 29, 2025Sarah Cannon Research Institute SCRI has announced a strategic alliance with AbbVieThe partnership is set to speed up the development of innovative cancer treatments by combining scientific expertise and improving clinical trial operations
InnoCare Gains Approval to Launch Clinical Trial of BCL2 Inhibitor Mesutoclax for Myelodysplastic Syndromes
Thursday, May 29, 2025InnoCare Pharma has received approval from the Centre for Drug Evaluation CDE under the China National Medical Products Administration NMPA to begin clinical trials of mesutoclax ICP a Bcell lymphoma BCL inhibitor for the treatment of myeloid maligna...
Eton Pharmaceuticals Secures FDA Approval for KHINDIVI Oral Solution
Thursday, May 29, 2025Eton Pharmaceuticals has received approval from the US Food and Drug Administration FDA for KHINDIVI hydrocortisone Oral Solution KHINDIVI is now the only FDAapproved oral liquid formulation of hydrocortisone Available in a mgml strength it has been...
